Mirum Pharmaceuticals, Inc. MIRM Unrealized Gain (Loss), Foreign Currency Transaction, before Tax
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossUnrealized.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s unrealized gain (loss), foreign currency transaction, before tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s unrealized gain (loss), foreign currency transaction, before tax?
- Mirum Pharmaceuticals, Inc. (MIRM) reported unrealized gain (loss), foreign currency transaction, before tax of -$1.1M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s unrealized gain (loss), foreign currency transaction, before tax changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s unrealized gain (loss), foreign currency transaction, before tax decreased by 266.9% year-over-year, from $658K to -$1.1M.
- What does unrealized gain (loss), foreign currency transaction, before tax mean?
- This reflects the impact of exchange rate fluctuations on monetary assets and liabilities denominated in currencies other than the company's functional currency. It captures gains or losses that have not yet been realized through actual cash settlement. This metric helps assess the company's exposure to international market volatility.